HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community

Proceedings of the National Academy of Sciences of the United States of America
Barbara L Triggs-RaineRobert A Hegele

Abstract

The prevalence of type 2 diabetes mellitus in the Oji-Cree of northwestern Ontario is the third highest in the world. A private mutation, G319S, in HNF1A, which encodes hepatic nuclear factor-1alpha (HNF-1alpha), was associated with Oji-Cree type 2 diabetes and was found in approximately 40% of affected subjects. The G319S mutation reduced the in vitro ability of HNF-1alpha to activate transcription by approximately 50%, with no effect on DNA binding or protein stability. There was no evidence of a dominant negative effect of the mutant protein. The impact of the G319S mutation at the population level was assessed by classifying subjects with type 2 diabetes according to HNF1A genotype and plotting the cumulative age of onset of diabetes. Disease onset was modeled satisfactorily by two-parameter sigmoidal functions for all diabetic subjects and all three HNF1A genotypes. Pairwise statistical comparisons showed significant between-genotype differences in t50 (all P < 0.00001), corresponding to the age at which half the subjects had become diabetic. Each dose of G319S accelerated median disease onset by approximately 7 years. Thus, the transactivation-deficient HNF1A G319S mutation affects the dynamics of disease onset. The demon...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jan 1, 1995·Methods in Enzymology·K E Neet
May 5, 1998·Molecular and Cellular Biology·Y H LeeF J Gonzalez
Mar 20, 1999·The Journal of Clinical Endocrinology and Metabolism·R A HegeleB Zinman
Dec 10, 1999·The Journal of Biological Chemistry·M VaxillaireM Pontoglio
Jun 7, 2000·Diabetes Care·R A HegeleC M Anderson
Aug 12, 2000·Journal of Experimental Botany·M G PoolmanS Thomas

❮ Previous
Next ❯

Citations

May 21, 2008·Current Atherosclerosis Reports·Constantin Polychronakos
May 6, 2003·Current Diabetes Reports·Mark I McCarthy
Apr 12, 2007·Current Diabetes Reports·Michael N Weedon, Timothy M Frayling
May 5, 2005·Atherosclerosis·Rebecca L PollexRobert A Hegele
May 3, 2003·Clinical Biochemistry·Robert A HegeleHenian Cao
Oct 3, 2002·Molecular Genetics and Metabolism·Simon M S Mitchell, Timothy M Frayling
Feb 28, 2003·Ageing Research Reviews·Anna L Gloyn
Nov 9, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R L PollexR A Hegele
May 25, 2004·Archives of Disease in Childhood·J WeillP Froguel
May 25, 2004·Archives of Disease in Childhood·A R GatradA Sheikh
Aug 3, 2005·The Journal of Clinical Investigation·Frances M Ashcroft
Jan 31, 2012·Journal of Nutrition and Metabolism·Kyle Millar, Heather J Dean
Apr 14, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Martine VaxillairePhilippe Froguel
Oct 26, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·R L PollexR A Hegele
Apr 5, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·K C ChiuM Wang
Nov 23, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K Navalón-GarcíaA Miliar-García
Dec 6, 2007·Pediatric Diabetes·Olivia Gill-Carey, Andrew T Hattersley
Jul 16, 2015·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Michael E JonassonChristine A Doucette
Dec 12, 2013·Molecular Metabolism·Maria Grazia Magro, Michele Solimena
Mar 30, 2004·Diabetes Care·Zachary T Bloomgarden
Oct 17, 2013·Diabetes Care·Allison B DartElizabeth A Sellers
Sep 8, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Barbara MlinarMarija Pfeifer
May 1, 2007·Current Opinion in Genetics & Development·Katharine R Owen, Mark I McCarthy
Apr 25, 2006·Endocrinology and Metabolism Clinics of North America·Martine Vaxillaire, Philippe Froguel
Jul 31, 2004·Stroke; a Journal of Cerebral Circulation·Khalid Z Al-ShaliRobert A Hegele
Nov 12, 2005·Stroke; a Journal of Cerebral Circulation·Robert A HegeleJ David Spence
Aug 7, 2018·Journal of Developmental Origins of Health and Disease·F JabarB Wicklow
Jul 10, 2018·Nucleic Acids Research·James A TimmonsWilliam E Kraus
Jun 28, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·L W Harries
May 14, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Robert A Hegele, Rebecca L Pollex
Mar 21, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·Joyce K DivineTheodore C Simon
Jun 29, 2004·Journal of Human Genetics·Junichi KamimuraNaomichi Matsumoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.